Xing L - Search Results

1

FDG PET/CT Tumor Dissemination Characteristic Predicts the Outcome of First-Line Systemic Therapy in Non-small Cell Lung Cancer.

Tan W, Zhang Y, Wang J, Zheng Z, Xing L, Sun X. Tan W, et al. Among authors: xing l. Acad Radiol. 2023 Dec;30(12):2904-2912. doi: 10.1016/j.acra.2023.03.027. Epub 2023 May 16. Acad Radiol. 2023. PMID: 37202226

2

[Effect of furazolidone on gut catecholamine levels in cysteamine-induced duodenal ulcer in the rat].

Xing LP, Zheng ZT. Xing LP, et al. Zhonghua Nei Ke Za Zhi. 1988 May;27(5):282-5, 326. Zhonghua Nei Ke Za Zhi. 1988. PMID: 3197495 Chinese. No abstract available.

3

Effect of furazolidone on gut catecholamine in cysteamine-induced duodenal ulcer in the rat.

Zheng ZT, Xing LP. Zheng ZT, et al. Among authors: xing lp. Scand J Gastroenterol. 1988 Oct;23(8):1020-4. doi: 10.3109/00365528809090164. Scand J Gastroenterol. 1988. PMID: 3201126

4

¹⁸F-FDG PET/CT radiomics predicts brain metastasis in I-IIIA resected Non-Small cell lung cancer.

Zheng Z, Wang J, Tan W, Zhang Y, Li J, Song R, Xing L, Sun X. Zheng Z, et al. Among authors: xing l. Eur J Radiol. 2023 Aug;165:110933. doi: 10.1016/j.ejrad.2023.110933. Epub 2023 Jun 20. Eur J Radiol. 2023. PMID: 37406583

5

Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study.

Gao Y, Sun X, Hou Y, Zhang M, Tan W, Zhang Y, Wang J, Zheng Z, Li C, Qi H, Hu M, Xing L. Gao Y, et al. Among authors: xing l. J Thorac Dis. 2023 Jun 30;15(6):3182-3196. doi: 10.21037/jtd-22-1685. Epub 2023 May 15. J Thorac Dis. 2023. PMID: 37426122 Free PMC article.

6

¹⁸F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer.

Wang J, Zheng Z, Zhang Y, Tan W, Li J, Xing L, Sun X. Wang J, et al. Among authors: xing l. Front Oncol. 2023 Jul 21;13:1185808. doi: 10.3389/fonc.2023.1185808. eCollection 2023. Front Oncol. 2023. PMID: 37546415 Free PMC article.

7

Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer.

Zhang Y, Tan W, Zheng Z, Wang J, Xing L, Sun X. Zhang Y, et al. Among authors: xing l. J Comput Assist Tomogr. 2023 Nov-Dec 01;47(6):906-912. doi: 10.1097/RCT.0000000000001496. Epub 2023 Jul 7. J Comput Assist Tomogr. 2023. PMID: 37948365

8

Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.

Qi H, Hou Y, Zheng Z, Zheng M, Qiao Q, Wang Z, Sun X, Xing L. Qi H, et al. Among authors: xing l. BMC Cancer. 2024 Mar 21;24(1):362. doi: 10.1186/s12885-024-12121-z. BMC Cancer. 2024. PMID: 38515096 Free PMC article. Clinical Trial.

9

MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis.

Qi H, Hou Y, Zheng Z, Zheng M, Sun X, Xing L. Qi H, et al. Among authors: xing l. Clin Radiol. 2024 Jul;79(7):515-525. doi: 10.1016/j.crad.2024.02.016. Epub 2024 Mar 19. Clin Radiol. 2024. PMID: 38637187 Free article.

10

Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients.

Cai S, Zhao M, Yang G, Li C, Hu M, Yang L, Xing L, Sun X. Cai S, et al. Among authors: xing l. Int Immunopharmacol. 2024 Aug 20;137:112434. doi: 10.1016/j.intimp.2024.112434. Epub 2024 Jun 17. Int Immunopharmacol. 2024. PMID: 38889507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,945 results

Search Page

Filters